Amgen Stock Plunges Following Disappointing Weight Loss Drug Data
A Large’s Story: Introducing Amgen The biotechnology world buzzed with anticipation, whispers of groundbreaking therapies and potential monetary windfalls swirling within the air. On the coronary heart of this pleasure stood Amgen, a titan of the business identified for its pioneering spirit and relentless pursuit of revolutionary medicines. Nevertheless, the current launch of scientific trial … Read more
